ENTITY

VISEN Pharmaceuticals (2561 HK)

14
Analysis
Health Care • China
VISEN Pharmaceuticals is an innovative biopharmaceutical company focused on endocrine diseases. It develops and commercializes therapies for conditions such as pediatric growth hormone deficiency, achondroplasia, and chronic hypoparathyroidism. The company was founded in 2018 and is headquartered in Suzhou, China.
more
Company Event • 11 Mar 2027 17:00 • Upcoming
Add To Calendar

H2 2026

Company Event • 27 Aug 2026 16:00 • Upcoming
Add To Calendar

H1 2026

Company Event • 12 Mar 2026 17:00 • Upcoming
Add To Calendar

H2 2025

Company Event • 27 Aug 2025 16:00 • Upcoming
Add To Calendar

H1 2025

Company Event • 13 Mar 2025 17:00 • Upcoming
Add To Calendar

H2 2024

No more events
x